TB Vaccine Advocacy Fellowship 2023

The TB Vaccine Advocacy Roadmap (TB Vax ARM) and Stop TB Partnership Working Group on New TB Vaccines are pleased to announce a new advocacy fellowship program, set to take place in February 2023 in the run up to World TB Day. The program will convene six fellows representing TB affected communities, advocates, and early career researchers from high TB burden countries for an online skill building and co-learning program. The goal of the program is to help cultivate a new generation of TB vaccine R&D advocates and stimulate more diverse advocacy efforts for TB vaccine R&D ahead of the UNHLM on TB in September 2023 and beyond.

Starting during the first week of February, the fellowship will feature approximately 15 hours of guided and self-guided working sessions over the course of four weeks, ending in the first week of March. Colleagues from the TB Vax ARM network will provide the fellows with learning moments throughout and short pre-session  assignments. Fellows will work together to develop an actionable campaign that can be implemented for World TB Day and hone their skills to develop and contribute to future advocacy campaigns.

Who can apply?

• Do you want to strengthen your knowledge and understanding of TB vaccine R&D?
• Are you interested in developing your advocacy skills in different formats and across stakeholder groups?
• Are you a member of an affected community, an advocate, or an Early Career Researcher and from a high TB burden country?

How to apply

• You can apply for the fellowship by clicking the Apply Now button below. The application should take no more than 30-45 minutes!
• Applications close 23 December at 23:59 Eastern Time
• Short-listed candidates will be asked to participate in a brief interview over Zoom during the first weeks of January 2023

What will fellows receive?

• A stipend (fixed payment)
• An opportunity to build their social media and advocacy skills
• Advocacy opportunities via the TB Vax ARM network and the WGNV

APPLY NOW: CLICK HERE